Trials / Completed
CompletedNCT02173886
A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- North Dakota State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to evaluate how the body absorbs and processes the sustained release (SR) and extended release (XL) medication bupropion (Wellbutrin®). Subject who are 1-3 years post gastric bypass surgery will be invited to participate. Non-surgical controls will also be enrolled based on a matching criteria to post gastric bypass subjects. Participants will be asked to complete two 12-hour study days approximately 11 days apart.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupropion SR and XL |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2014-06-25
- Last updated
- 2016-09-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02173886. Inclusion in this directory is not an endorsement.